Search
Furazidin
go.drugbank.com/drugs/DB13475ExperimentalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseBetamipron
go.drugbank.com/drugs/DB19858ExperimentalBetamipron is a small molecule drug. Betamipron has a monoisotopic molecular weight of 193.07 Da.
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseProtocatechualdehyde
go.drugbank.com/drugs/DB11268ApprovedProtocatechualdehyde possesses antiproliferative and pro-apoptotic properties against human breast cancer cells and colorectal cancer cells by reducing the expression of pro-oncogenes β-catenin and cyclin
Exebacase
go.drugbank.com/drugs/DB16161InvestigationalPlacebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia).
Fenpyroximate
go.drugbank.com/drugs/DB16164InvestigationalFenpyroximate is under investigation in clinical trial NCT02533336 (The Effectiveness of Non-pyrethroid Insecticide-treated Durable Wall Liners as a Method for Malaria Control in Endemic Rural Tanzania
BEA-17
go.drugbank.com/drugs/DB18574Experimental[L48330] It is under investigation for the treatment of glioblastoma.
Levonadifloxacin
go.drugbank.com/drugs/DB16219InvestigationalLevonadifloxacin is under investigation in clinical trial NCT03405064 (Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)).
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseFlomoxef
go.drugbank.com/drugs/DB11935InvestigationalFlomoxef has been used in trials studying the treatment of Urinary Tract Infection.
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseMeclofenoxate
go.drugbank.com/drugs/DB13758InvestigationalCategories: Psychostimulants, Agents Used for ADHD and Nootropics, Compounds used in a research, industrial, or household settingALMB-0166
go.drugbank.com/drugs/DB17937InvestigationalALMB-0166 is a umanized connexin 43 (Cx43) monoclonal antibody being investigated for the treatment of acute spinal cord injury. It was granted FDA orphan designation in November 2018.[L47067]